Enlimomab | Interleukin Related interleukin-related.com

Product Name :
Enlimomab

Search keywords :
Enlimomab

drugId :
null

Target Vo:
Intercellular adhesion molecule-1

Target Vo Short Name :
ICAM1

Moa_Name:
Intercellular adhesion molecule-1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Boehringer Ingelheim Gmbh

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Rejection of liver transplantation

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Filamin A Antibody
eIF4EBP1 Antibody
LDLR Antibody: LDLR Antibody is an unconjugated, approximately 92 kDa, rabbit-derived, anti-LDLR polyclonal antibody. LDLR Antibody can be used for: WB, ELISA, Flow-Cyt, ICC expriments in human, mouse, and predicted: rat, dog, pig, cow, horse, rabbit, guinea pig background without labeling.

Author: Interleukin Related

Related Posts